日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Single-cell transcriptome analysis reveals DNMT1(+) epithelial cells promote lymphatic metastasis via CXCL17-mediated TAM infiltration

单细胞转录组分析揭示DNMT1(+)上皮细胞通过CXCL17介导的TAM浸润促进淋巴转移。

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-026-08032-1
Yang, Guo; Liu, Jiayu; Guo, Tingting; Zhu, Junlong; Li, Tinghao; Sun, Yan; Qin, Zijia; Gan, Junlin; Li, Xinyuan; He, Weiyang
上皮细胞
单细胞
DNMT1
CXCL1
细胞生物学
发表日期：2026
文献求助 收藏

The FN1-ITGB4 Axis Drives Acquired Chemoresistance in Bladder Cancer by Activating FAK Signaling.

FN1-ITGB4轴通过激活FAK信号通路驱动膀胱癌获得性化疗耐药性。

期刊:Oncology Research
影响因子:4.1
doi:10.32604/or.2025.072084
Zhang Xiaoyu, Zong RenFei, Sun Yan, Chen Nan, Zhu Kunyao, Tong Hang, Li Tinghao, Zhu Junlong, Qin Zijia, Wu Linfeng, Wang Aimin, He Weiyang
肿瘤
肿瘤免疫
FAK
信号转导
膀胱癌
发表日期：2026
文献求助 收藏

RBM11 drives malignant progression of bladder cancer by regulating GNPDA1-PKM2 axis.

RBM11 通过调节 GNPDA1-PKM2 轴驱动膀胱癌的恶性进展。

期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2026.115402
Tong Hang, Li Tinghao, Zhu Junlong, Dou Qian, Yu Qiong, Sun Yan, He Weiyang
膀胱癌
肿瘤
发表日期：2026
文献求助 收藏

Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer.

癌症相关成纤维细胞衍生的 CXCL14 通过增强膀胱癌中的核苷酸切除修复来驱动顺铂化疗耐药性

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03487-4
Li Tinghao, Zhu Kunyao, Tong Hang, Sun Yan, Zhu Junlong, Qin Zijia, Chen Junrui, Wu Linfeng, Zhang Xiaoyu, Wang Aimin, Gou Xin, Yin Hubin, He Weiyang
细胞生物学
膀胱癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Integrative multi-omics and single-cell transcriptomics reveal ARHGEF12 driving chemoresistance in bladder cancer

整合多组学和单细胞转录组学揭示ARHGEF12驱动膀胱癌化疗耐药性

期刊:Hereditas
影响因子:2.5
doi:10.1186/s41065-025-00606-1
Zhu, Kunyao; Zhang, Zhejiao; Li, Tinghao; Sun, Yan; Zhu, Junlong; Wu, Linfeng; Zhang, Xiaoyu; Tong, Hang; Qin, Zijia; Wang, Aimin; He, Weiyang
肿瘤
肿瘤免疫
ARH
细胞生物学
膀胱癌
单细胞
发表日期：2025
文献求助 收藏

Unraveling the mechanism of tetracycline-induced renal injury: an evaluation of drug safety based on network toxicology and molecular dynamics simulations

揭示四环素类药物引起肾损伤的机制：基于网络毒理学和分子动力学模拟的药物安全性评价

期刊:
影响因子:
doi:10.1186/s40360-025-00991-3
Wu, Yimao; Liang, Yalun; Liang, Jintao; Chen, Zifeng; Tang, Bo; Zhu, Junlong; Shen, Yifeng
毒理研究
肾损伤
发表日期：2025
文献求助 收藏

The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model

头孢哌酮/舒巴坦相关凝血功能障碍的临床特征和危险因素：列线图预测模型

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1505653
Xu, Changjing; Zhu, Junlong; Tu, Kun; Tang, Hui; Zhou, Xinxin; Li, Qiuyu; Chen, Kun; Yang, Xuping; Huang, Yilan
发表日期：2024
文献求助 收藏

Idiopathic multiple peripheral arterial dissections:A case report

特发性多发性周围动脉夹层：病例报告

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2024.e34085
Zhu, Junlong; He, Huqiang; Xu, Changjing; Wu, Ya; Xu, Tongjie; Chen, Hao; Liu, Yong
发表日期：2024
文献求助 收藏

Nucleolar protein 3 promotes proliferation of bladder cancer cells through the PI3K-Akt pathway.

核仁蛋白3通过PI3K-Akt通路促进膀胱癌细胞增殖

期刊:World Journal of Surgical Oncology
影响因子:2.5
doi:10.1186/s12957-024-03600-5
Wu Linfeng, Zhu Kunyao, Sun Yan, Li Tinghao, Zhu Junlong, Tong Hang, Zhang Xiaoyu, Chen Junrui, Yin Hubin, He Weiyang
细胞生物学
膀胱癌
PI3K/Akt
肿瘤免疫
发表日期：2024
文献求助 收藏

Immune Co-inhibitory Receptors CTLA-4, PD-1, TIGIT, LAG-3, and TIM-3 in Upper Tract Urothelial Carcinomas: A Large Cohort Study

上尿路上皮癌中的免疫共抑制受体 CTLA-4、PD-1、TIGIT、LAG-3 和 TIM-3：一项大型队列研究

期刊:Journal of Immunotherapy
影响因子:3.2
doi:10.1097/CJI.0000000000000466
Shengming Jin, Zhi Shang, Wenwen Wang, Chengyuan Gu, Yu Wei, Yu Zhu, Chen Yang, Tiantian Zhang, Yao Zhu, Yiping Zhu, Junlong Wu, Dingwei Ye
免疫
发表日期：2023
文献求助 收藏